Pascale Dutailly

CaboPoint: Interim results from a phase 2 study of cabozantinib after checkpoint inhibitor (CPI) therapy in patients with advanced renal cell carcinoma (RCC).

Laurence Albigès, Thomas Powles, Anand Sharma et al. · Journal of Clinical Oncology · 2023 · 26 citations

Cardiovascular Pharmacology, Checkpoint Inhibitor, Pharmacotherapy +19

Characterizing Short Stature by Insulin-like Growth Factor Axis Status and Genetic Associations: Results From the Prospective, Cross-sectional, Epidemiogenetic EPIGROW Study

Peter Clayton, Mireille Bonnemaire, Pascale Dutailly et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 24 citations · Full text

Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Growth Factor-1 and Growth Hormone Sufficiency: Results from a Randomized, Multicenter, Open-Label, Parallel-Group, Active Treatment-Controlled Trial

Philippe Backeljauw, Bradley S. Miller, Pascale Dutailly et al. · Hormone Research in Paediatrics · 2015 · 23 citations · Full text

Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer

Jürgen Breul, Eija Lundström, Daniela Purcea et al. · Advances in Therapy · 2016 · 21 citations · Full text

Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer

T. Lebret, Mathieu Rouanne, O. Y. Hublarov et al. · Therapeutic Advances in Urology · 2015 · 14 citations · Full text